Cue Biopharma, Inc. Banner Image

Cue Biopharma, Inc.

  • Ticker CUE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Cue Biopharma, Inc. Logo Image
  • 11-50 Employees
  • Based in Cambridge, Massachusetts
Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells) is designed to harness the body’sMore intrinsic immune system without the need for ex vivo manipulation.
4.8 / 5.0 (198)

Cue Biopharma, Inc. reports have an aggregate usefulness score of 4.8 based on 198 reviews.

Cue Biopharma, Inc.

Most Recent Annual Report

Cue Biopharma, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Cue Biopharma, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!